Stock listing

ASX:ALC Alcidion Group Limited Share Price

Follow Alcidion Group Limited into a list and get an email when it puts out news.

Share price · ASX:ALC

$1.27 AUD +0.07 (+6.3%)

Close on Nov 20, 2026

Past year +27.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.22 – $1.29 AUDNov 20, 2026
Volume
78,049 sharesNov 20, 2026
Market cap
$171.4M AUDAt the close on Nov 20, 2026 · price × 135.0M shares outstanding
52-week range
$0.83 – $1.45 AUDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$20,363 AUDMedian day 5,871 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Alcidion Group Limited logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:ALC · AUD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.27+0.075+6.3%$1.215$1.285$1.21578,049
$1.195-0.055-4.4%$1.20$1.225$1.19561,043
$1.250.000.0%$1.30$1.30$1.1947,434
$1.25+0.10+8.7%$1.15$1.25$1.1546,979
$1.15+0.10+9.5%$1.10$1.20$1.1017,246
$1.05-0.10-8.7%$1.15$1.15$1.0517,288
$1.15+0.10+9.5%$1.10$1.15$1.107,195
$1.050.000.0%$1.075$1.10$1.051,378
$1.050.000.0%$1.10$1.10$1.05427,341
$1.05-0.10-8.7%$1.15$1.15$1.05353
$1.15+0.10+9.5%$1.05$1.15$1.054,274
$1.05-0.05-4.5%$1.10$1.10$1.058,297
$1.10+0.05+4.8%$1.10$1.10$1.0751,836
$1.05-0.05-4.5%$1.10$1.10$1.052,984
$1.10-0.05-4.3%$1.20$1.20$1.07546,575
$1.150.000.0%$1.15$1.20$1.1517,121
$1.15+0.05+4.5%$1.15$1.15$1.109,009
$1.10+0.10+10.0%$1.05$1.10$1.0029,289
$1.000.000.0%$0.99$1.05$0.9713,342
$1.00+0.04+4.2%$0.95$1.00$0.955,559
$0.96-0.01-1.0%$0.97$0.99$0.957,607
$0.97+0.01+1.0%$0.97$0.97$0.955536
$0.96+0.01+1.1%$0.95$0.97$0.946,121
$0.95-0.03-3.1%$0.99$0.99$0.9515,352
$0.98-0.01-1.0%$0.98$1.00$0.97982
$0.99+0.01+1.0%$0.99$1.00$0.982,881
$0.98-0.02-2.0%$0.98$0.98$0.973,678
$1.000.000.0%$1.00$1.00$0.985,050
$1.00+0.01+1.0%$0.99$1.00$0.987,959
$0.99-0.01-1.0%$0.99$1.025$0.9817,700
$1.00-0.05-4.8%$1.05$1.05$0.9917,020
$1.05+0.05+5.0%$1.05$1.05$1.001,795
$1.000.000.0%$1.00$1.05$1.0011,892
$1.000.000.0%$1.00$1.05$1.002,775
$1.00-0.05-4.8%$1.00$1.05$1.003,178
$1.05-0.05-4.5%$1.05$1.10$1.0019,615
$1.10+0.05+4.8%$1.05$1.10$1.0021,501
$1.050.000.0%$1.00$1.05$1.00295
$1.050.000.0%$1.05$1.05$1.005,622
$1.05+0.025+2.4%$1.025$1.05$1.002,197
$1.025+0.025+2.5%$1.00$1.05$1.001,331
$1.000.000.0%$1.025$1.05$1.001,132
$1.000.000.0%$1.00$1.05$1.001,444
$1.00+0.01+1.0%$1.00$1.05$0.995,566
$0.99-0.01-1.0%$1.00$1.025$0.993,225
$1.000.000.0%$1.05$1.05$1.004,692
$1.000.000.0%$1.05$1.05$1.00934
$1.000.000.0%$1.00$1.00$0.9910,910
$1.00-0.05-4.8%$1.00$1.00$0.994,366
$1.050.000.0%$1.00$1.05$0.995,501
$1.05+0.05+5.0%$1.00$1.05$1.006,644
$1.000.000.0%$1.00$1.00$1.00891
$1.00-0.05-4.8%$1.025$1.05$1.00903
$1.050.000.0%$1.00$1.05$1.003,445
$1.05+0.075+7.7%$0.98$1.05$0.9822,346
$0.975+0.005+0.5%$0.97$0.99$0.978,192
$0.970.000.0%$0.97$0.97$0.954,188
$0.970.000.0%$0.97$0.97$0.9315,022
$0.970.000.0%$0.98$0.98$0.953,835
$0.97+0.01+1.0%$0.97$0.97$0.954,502
$0.96+0.03+3.2%$0.94$0.96$0.9317,730
$0.93-0.03-3.1%$0.96$0.97$0.9313,863
$0.96+0.02+2.1%$0.96$0.97$0.9454,219
$0.94+0.03+3.3%$0.93$0.95$0.9121,251
$0.91-0.04-4.2%$0.95$0.95$0.917,796
$0.95+0.04+4.4%$0.92$0.95$0.89583,370

Splits

1 split · ASX:ALC · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
Ticker
ASX:ALC
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
ASX
Currency
AUD

What changed lately

Latest news

Update - Consolidation/Split - ALC

Nov 12, 2026

Closed $1.15 (+9.5%) on Nov 13, 2026

Consolidation of Capital Approved

Nov 12, 2026

Closed $1.15 (+9.5%) on Nov 13, 2026

Results of 2026 Annual General Meeting

Nov 12, 2026

Closed $1.15 (+9.5%) on Nov 13, 2026

Trading Update

Oct 28, 2026

Closed $1.15 (0.0%) on Oct 29, 2026

Notification of buy-back - ALC

Oct 26, 2026

Closed $1.10 (+10.0%) on Oct 27, 2026

On-Market Share Buy-Back Announcement

Oct 26, 2026

Closed $1.10 (+10.0%) on Oct 27, 2026

Consolidation/Split - ALC

Oct 8, 2026

Closed $0.99 (-1.0%) on Oct 9, 2026

All Alcidion Group Limited news

Alcidion Group Limited on 6ix

Sector
Health care
Industry
Health care services
News releases
43 in the last 12 months · 249 in all · newest Nov 22, 2026 · oldest 2016
Decks
54 decks · latest Nov 12, 2026

Valuation

P/E 75.0× against a median of 17.7×: the highest of 8 Health care services companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$151.6M AUD
P/E
75.0×
EV/sales
2.9×
EV/EBITDA
20.1×
Price/book
1.9×
Gross margin
17.8%
Operating margin
4.9%
Net margin
4.4%
Debt to equity
0.0×
Beta
No index for this market yet

Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Alcidion Group Limited · ASX:ALCUS$113.5MUS$100.4M75.0×2.9×20.1×1.9×4.4%0.0×n/a
Nordhealth AS · OSL:NORDHUS$121.9MUS$108.1Mn/a1.9×45.6×2.0×−29.9%0.0×n/a
CHC Healthcare Group · TWSE:4164US$121.1MUS$251.3M17.7×1.8×7.3×0.5×4.9%0.8×n/a
Ekachai Medical Care Public Company Limited · SET:EKHUS$119.7MUS$99.99M15.0×2.6×8.3×1.8×20.9%0.0×n/a
Honliv Healthcare Management Group Co Ltd · HKEX:9906US$119.4MUS$100.2Mn/an/an/a1.7×n/a0.3×n/a
GPT Healthcare Limited · NSE:GPTHEALTHUS$118.6MUS$118.6M23.3×2.2×12.1×4.1×9.6%0.0×n/a
Icon Group Ltd · TASE:ICONUS$117.7MUS$193.0M7.8×0.4×6.5×1.4×2.9%0.9×n/a
Hydreight Technologies Inc · TSXV:NURSUS$114.2MUS$106.4M24.3×1.9×17.7×4.2×8.6%0.2×0.95
Kindstar Globalgene Technology, Inc. · HKEX:9960US$111.6M−US$99.19Mn/a−0.7×n/a0.3×−6.3%0.1×n/a
Auna SA · NYSE:AUNAUS$110.3MUS$1.05B24.8×0.8×4.3×0.2×0.3%2.0×1.03
BenQ BM Holding Cayman Corp. · HKEX:2581US$110.2MUS$43.03M7.7×0.1×0.8×0.3×3.5%0.1×n/a
Median of the othersUS$118.2MUS$107.3M17.7×1.8×7.8×1.6×3.5%0.2×0.99

Forecasts

Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
0.15 AUD · Analysts' mean
EPS, year to Jun 2027
0.002 · 4 analysts
Revenue, year to Jun 2027
55.65M · 4 analysts

Team and board

Officers

OfficerRole
Kate QuirkeGroup Managing Director/Chief Executive Officer
Matthew GeppChief Financial Officer
Julia StevensChief Operating Officer
Amanda JamesChief People Officer
Andy SmallmanDirector of Strategic Business Development
Kaye HockingChief Product Officer
Nick WhiteChief Marketing Officer
Paul DeffleyChief Medical Officer/UK Managing Director
Sean WalkerChief Technology Officer
Tracy McClellandChief Clinical Information Officer

Board

DirectorRole
Rebecca WilsonCHAIR
Andrew WayNon-Executive Director
Daniel SharpNon-Executive Director
Will SmartNon-Executive Director

Events

QuarterResultsShare move
Quarter to Sep 30, 2025Dec 3, 20250.0%
Q4 2025Aug 27, 20250.0%
Quarter to Mar 31, 2025May 28, 2025+7.4%
Q2 2025Feb 26, 2025+3.3%
Quarter to Sep 30, 2024Nov 27, 2024−1.5%
Q4 2024Aug 29, 2024−2.7%
Quarter to Mar 31, 2024May 29, 2024−1.8%
Q2 2024Feb 27, 2024−4.3%
Q2 2023Feb 23, 2023 · After close0.0%
Q4 2022Aug 29, 2022 · After close+3.3%
All 13 quarters
QuarterResultsShare move
Q2 2022Feb 22, 2022 · After close0.0%
Q4 2021Aug 23, 2021 · After close0.0%
Q2 2021Feb 24, 2021 · After close+8.7%

Open Events

Decks

DeckKindSlidesDate
Shareholder Meeting (November 2026)Shareholder meeting35 slidesNov 12, 2026
FY2026 Earnings PresentationEarnings34 slidesAug 19, 2026
Non-Deal Roadshow (June 2026)Roadshow36 slidesJun 29, 2026
H1 2026 Earnings PresentationEarnings36 slidesFeb 26, 2026
Shareholder Meeting (October 2025)Shareholder meeting33 slidesOct 16, 2025
Investor Presentation (September 2025)Investor deck40 slidesSep 15, 2025
FY2025 Earnings PresentationEarnings28 slidesAug 28, 2025
Investor Presentation (March 2025)Investor deck37 slidesMar 12, 2025
Coffee Microcaps Results Webinar March 2025Conference19 slidesMar 7, 2025
H1 2025 Earnings PresentationEarnings25 slidesFeb 27, 2025
Show 50 decks
DeckKindSlidesDate
Shareholder Meeting (October 2024)Shareholder meeting42 slidesOct 23, 2024
FY2024 Earnings PresentationEarnings28 slidesAug 29, 2024
H1 FY2024 Earnings PresentationEarnings29 slidesFeb 28, 2024
Shareholder Meeting (November 2023)Shareholder meeting14 slidesNov 20, 2023
Investor Presentation (August 2023)Investor deck31 slidesAug 24, 2023
Canaccord Genuity 43rd Annual Growth Conference 2023Conference20 slidesAug 10, 2023
H1 FY2023 Earnings PresentationEarnings28 slidesFeb 24, 2023
Shareholder Meeting (November 2022)Shareholder meeting15 slidesNov 30, 2022
FY2022 Earnings PresentationEarnings30 slidesSep 12, 2022
Investor Presentation (August 2022)Investor deck13 slidesAug 30, 2022
H1 2022 Earnings PresentationEarnings21 slidesFeb 23, 2022
Q2 FY22 Earnings PresentationEarnings6 slidesJan 27, 2022
Investor Presentation (December 2021)Investor deck43 slidesDec 7, 2021
Shareholder Meeting (November 2021)Shareholder meeting13 slidesNov 17, 2021
Q1 FY22 Earnings PresentationEarnings5 slidesOct 26, 2021
FY2021 Earnings PresentationEarnings31 slidesSep 15, 2021
FY2021 Earnings PresentationEarnings16 slidesAug 24, 2021
Investor Presentation (June 2021)Investor deck15 slidesJun 30, 2021
Investor Presentation (April 2021)Investor deck17 slidesApr 15, 2021
H1 FY2021 Earnings PresentationEarnings9 slidesFeb 25, 2021
Shareholder Meeting (November 2020)Shareholder meeting11 slidesNov 19, 2020
FY2020 Earnings PresentationEarnings20 slidesSep 9, 2020
Non-Deal Roadshow (February 2020)Roadshow27 slidesFeb 11, 2020
Shareholder Meeting (November 2019)Shareholder meeting17 slidesNov 14, 2019
Investor Presentation (November 2019)Investor deck12 slidesNov 5, 2019
Investor Presentation (October 2019)Investor deck32 slidesOct 14, 2019
Investor Presentation (May 2019)Investor deck16 slidesMay 1, 2019
Investor Presentation (March 2019)Investor deck15 slidesMar 18, 2019
Investor Presentation (October 2018)Investor deck18 slidesOct 15, 2018
Merger or Acquisition (May 2018)Merger or acquisition24 slidesMay 2, 2018
Shareholder Meeting (November 2017)Shareholder meeting9 slidesNov 24, 2017
Investor Presentation (May 2017)Investor deck19 slidesMay 29, 2017
TechKnow Invest Roadshow 2017Conference24 slidesMar 15, 2017
Shareholder Meeting (November 2016)Shareholder meeting24 slidesNov 29, 2016
TechKnow Invest Roadshow 2016Conference22 slidesOct 6, 2016
Investor Presentation (August 2016)Investor deck57 slidesAug 31, 2016
Health Informatics (July 2016)Conference17 slidesJul 26, 2016
Investor Presentation (May 2016)Investor deck17 slidesApr 29, 2016
Investor Presentation (February 2016)Investor deck38 slidesFeb 26, 2016
Miya ED webinar (October 2015)Conference11 slidesOctober 2015

This page holds 50 of 54 decks. Open Decks

Open Decks

Financials

Annual, in AUD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue51.6M40.8M37.1M40.4M34.4M25.9M18.6M16.9M4.18M3.46M
Cost of revenue42.5M4.80M5.14M39.1M31.1M22.4M18.2M11.0M2.77M1.18M
Gross profit9.16M36.0M31.9M1.25M3.29M3.52M401.2K5.91M1.40M2.28M
Selling, general and administrative28.5M1.09M28.3M28.3M22.4M17.4M6.27M13.8M3.95M3.94M
Operating income2.55M7.81M-7.65M-4.73M-1.73M-174.0K-2.32M-125.5K-2.21M-2.14M
Depreciation and amortization5.00M4.59M4.10M3.19M2.26M457.0K247.4K65.9K47.2K55.3K
EBITDA7.55M12.4M-3.55M-1.54M528.0K283.0K-2.07M-59.6K-2.16M-2.09M
Interest expense57.0K81.0K103.0K125.0K68.0K3.00K74.4K15.6K73.7K0
Income before tax1.32M320.0K-8.70M-4.74M-3.91M-934.0K-4.02M-109.9K-2.14M-2.04M
Income tax-968.0K1.33M-282.0K-1.12M504.0K1.31M-941.6K-25.8K-45.9K21.9K
Net income2.29M1.65M-8.42M-3.62M-4.41M-2.24M-3.08M-84.2K-2.09M-2.06M
Earnings per share, basic0.000.00-0.01-0.00-0.00-0.00-0.00-0.00-0.00-0.00

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents20.6M17.7M11.8M14.6M17.3M25.0M15.9M3.17M2.89M5.33M
Short-term investments73.5K
Receivables6.06M3.68M5.21M4.74M7.25M4.11M3.83M3.42M499.5K249.5K
Inventory111
Current assets29.7M23.7M18.5M21.0M26.3M30.3M20.2M6.87M4.48M6.64M
Property, plant and equipment1.59M1.97M2.87M3.27M549.0K549.9K157.6K90.0K97.8K
Goodwill68.7M67.8M67.8M67.8M67.8M25.5M15.4M15.4M771.1K
Total assets121.9M115.6M114.5M120.7M128.4M58.4M39.4M24.9M5.83M6.83M
Accounts payable2.26M616.0K305.0K2.13M1.65M766.0K991.3K509.2K201.4K99.6K
Current liabilities24.4M20.9M19.2M21.3M24.4M13.0M9.41M11.5M2.39M1.38M
Total debt814.0K1.41M1.70M2.15M2.48M181.0K315.9K
Total liabilities31.0M27.8M27.5M30.5M34.4M13.2M9.70M11.6M2.50M1.41M
Shareholders' equity90.9M87.8M86.9M90.2M94.0M45.2M29.7M13.2M3.33M5.42M
Shares outstanding1.34B1.34B1.32B1.27B1.16B1.02B953.1M821.3M607.8M604.2M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations6.85M5.76M-7.13M169.0K996.0K1.54M-2.02M1.99M-1.83M-519.4K
Capital spending-226.0K-125.0K-53.0K-454.0K-311.0K-313.0K-123.8K-264.8K-23.9K-14.6K
Free cash flow6.62M5.64M-7.18M-285.0K685.0K1.23M-2.14M1.73M-1.85M-534.0K
Cash from investing-1.70M-125.0K-53.0K-3.14M-59.7M-9.84M-362.0K-1.74M-615.6K-14.6K
Cash from financing-800.0K-764.0K4.34M-616.0K51.3M17.2M15.2M31.4K31.4K219.9K
Share buybacks0-399.0K051.9M17.5M15.4M0225.0K
Change in cash2.94M5.90M-2.84M-2.70M-7.69M9.08M12.8M281.5K-2.44M-314.1K

Open Financials

Filings

FilingDateTypeFiled with
Update - Notification of buy-back - ALCNov 22, 2026Treasury share statusASX
Update - Notification of buy-back - ALCNov 19, 2026Treasury share statusASX
Update - Notification of buy-back - ALCNov 18, 2026Notification letterASX
Update - Notification of buy-back - ALCNov 17, 2026Treasury share statusASX
Update - Notification of buy-back - ALCNov 16, 2026Treasury share statusASX
Update - Notification of buy-back - ALCNov 15, 2026Treasury share statusASX
Update - Consolidation/Split - ALCNov 12, 2026Other filingsASX
Consolidation of Capital ApprovedNov 12, 2026Other filingsASX
Results of 2026 Annual General MeetingNov 12, 2026Meeting outcomeASX
2026 Annual General Meeting Chair Address & PresentationNov 11, 2026Meeting noticeASX
Show 200 filings
FilingDateTypeFiled with
Trading UpdateOct 28, 2026Operations updateASX
Trading UpdateOct 28, 2026Operations updateASX
Notification of buy-back - ALCOct 26, 2026Treasury share statusASX
On-Market Share Buy-Back AnnouncementOct 26, 2026Treasury share statusASX
Notification of cessation of securities - ALCOct 15, 2026FinancingASX
Consolidation/Split - ALCOct 8, 2026Other filingsASX
Proposed Consolidation of CapitalOct 8, 2026Other filingsASX
2026 Notice of Annual General MeetingOct 8, 2026Meeting noticeASX
Change of Director's Interest NoticeOct 7, 2026Ownership change noticeASX
Northern Care Alliance to implement ALC's Miya PrecisionSep 29, 2026Operations updateASX
Application for quotation of securities - ALCSep 3, 2026FinancingASX
Relief from Quarterly ReportingSep 2, 2026Quarterly reportASX
Change of Director's Interest NoticeAug 27, 2026Ownership change noticeASX
Change of Director's Interest NoticeAug 26, 2026Ownership change noticeASX
Change in substantial holdingAug 24, 2026Ownership change noticeASX
FY26 Results PresentationAug 18, 2026Other filingsASX
FY26 Results ReleaseAug 18, 2026Other filingsASX
FY26 Appendix 4E and Annual ReportAug 18, 2026Annual reportASX
FY26 Corporate Governance StatementAug 18, 2026Other filingsASX
FY26 Appendix 4GAug 18, 2026Other filingsASX
ALC FY26 Full Year Results and Investor Webcast NotificationAug 11, 2026ResultsASX
Notification regarding unquoted securities - ALCAug 11, 2026Other filingsASX
Q4 FY26 Quarterly Activities Report and Appendix 4CJul 22, 2026Quarterly reportASX
Reconfirming FY26 Guidance and Acquisition CompletionJun 28, 2026GuidanceASX
ALC signs 7-year contract with UHSussex for EPR platformMay 24, 2026Operations updateASX
Acquisition of the Kyra flow products from Telstra HealthMay 17, 2026Acquisition or disposalASX
Q3 FY26 Quarterly Activities Report and Appendix 4CApr 28, 2026Quarterly reportASX
H1 FY26 Results PresentationFeb 25, 2026Other filingsASX
H1 FY26 Results ReleaseFeb 25, 2026Other filingsASX
H1 FY26 Appendix 4D and Half Year ReportFeb 25, 2026Interim reportASX
Dual AU and UK Medical Device Registration for AI CapabilityFeb 18, 2026Operations updateASX
Q2 FY26 Quarterly Activities Report and Appendix 4CJan 14, 2026Quarterly reportASX
Alcidion Selected as Preferred EPR SupplierJan 7, 2026Operations updateASX
Alcidion expands contract with Leidos AustraliaNov 16, 2025Operations updateASX
Q1 FY26 Quarterly Activities Report and Appendix 4COct 27, 2025Quarterly reportASX
2025 Annual General Meeting Chair Address & PresentationOct 16, 2025Meeting noticeASX
Alcidion expands contract with NCICSep 22, 2025Operations updateASX
FY25 Results PresentationAug 27, 2025Other filingsASX
FY25 Results ReleaseAug 27, 2025Other filingsASX
FY25 Appendix 4EAug 27, 2025ResultsASX
Q4 FY25 Quarterly Activities Report and Appendix 4CJul 23, 2025Quarterly reportASX
Guidance UpgradeJun 22, 2025GuidanceASX
Q3 FY25 Quarterly Activities Report and Appendix 4CApr 21, 2025Quarterly reportASX
H1 FY25 Results PresentationFeb 26, 2025ResultsASX
H1 FY25 Results ReleaseFeb 26, 2025ResultsASX
H1 FY25 Appendix 4D and Half Year ReportFeb 26, 2025Interim reportASX
Alcidion secures 10-year contract with NCICFeb 20, 2025Acquisition or disposalASX
ALC secures contract with Hywel Dda University Health BoardFeb 10, 2025Operations updateASX
Q2 FY25 Quarterly Activities Report and Appendix 4CJan 29, 2025Quarterly reportASX
Alcidion secures contract with Peninsula HealthNov 21, 2024Other filingsASX
Alcidion secures contract with NALHNNov 13, 2024Operations updateASX
Q1 FY25 Quarterly Activities Report and Appendix 4COct 30, 2024Quarterly reportASX
2024 Annual General Meeting Chair Address & PresentationOct 23, 2024Meeting noticeASX
FY24 Results Investor PresentationAug 28, 2024Other filingsASX
FY24 Results Media ReleaseAug 28, 2024Other filingsASX
FY24 Appendix 4EAug 28, 2024ResultsASX
Q4 FY24 Quarterly Activities Report and Appendix 4CJul 29, 2024Quarterly reportASX
Alcidion Selected as Preferred EPR Supplier by North CumbriaJul 23, 2024Operations updateASX
Long term partnership signed with Hume Rural Health AllianceJul 17, 2024Material contractASX
Response to ASX Price QueryMay 3, 2024Explanation requestASX
Q3 FY24 Quarterly Activities Report and Appendix 4CApr 17, 2024Quarterly reportASX
Alcidion signs $3.4M contract extension with DGT NHS TrustMar 5, 2024Material contractASX
Alcidion H1 FY2024 ResultsFeb 27, 2024Other filingsASX
Investor Presentation - Half Year Results - H1 FY2024Feb 27, 2024Interim reportASX
Alcidion FY24 Appendix 4D and Half Year ReportFeb 27, 2024Interim reportASX
Q2 FY24 Quarterly Activities Report and Appendix 4CJan 30, 2024Quarterly reportASX
ALC signs $23.3M South Tees contract extension until 2033Dec 10, 2023Material contractASX
Share Purchase Plan AnnouncementOct 31, 2023FinancingASX
Quarterly Activities Report & Placement Announcement/App 4COct 31, 2023Quarterly reportASX
Trading HaltOct 30, 2023Trading halt or suspensionASX
FY23 Results Media ReleaseAug 23, 2023Other filingsASX
FY23 Investor PresentationAug 23, 2023Other filingsASX
FY23 Appendix 4EAug 23, 2023ResultsASX
Q4 FY23 Quarterly Activities Report and Appendix 4CJul 26, 2023Quarterly reportASX
Alcidion signs two Silverlink PCS contract renewalsMay 29, 2023Other filingsASX
Q3 FY23 Quarterly Activities Report and Appendix 4CApr 26, 2023Quarterly reportASX
S&P DJI Announces March 2023 Quarterly RebalanceMar 3, 2023Other filingsASX
Alcidion H1 FY2023 ResultsFeb 23, 2023Other filingsASX
Investor Presentation - Half Year Results - H1 FY2023Feb 23, 2023Interim reportASX
Alcidion FY23 Appendix 4D and Half Year ReportFeb 23, 2023Interim reportASX
Q2 FY23 Quarterly Activities Report and Appendix 4CJan 29, 2023Quarterly reportASX
Alcidion extends partnership with Leidos AustraliaDec 18, 2022Other filingsASX
S&P DJI Announces December 2022 Quarterly RebalanceDec 2, 2022Other filingsASX
UHS NHS Foundation Trust procures Miya Precision for EPRNov 30, 2022Other filingsASX
Q1 FY23 Quarterly Activities Report (Updated Webcast Link)Oct 30, 2022Quarterly reportASX
Q1 FY23 Quarterly Activities Report and Appendix 4COct 30, 2022Quarterly reportASX
FY22 Investor PresentationAug 29, 2022Other filingsASX
FY22 Media ReleaseAug 29, 2022Other filingsASX
FY22 Appendix 4EAug 29, 2022ResultsASX
Q4 FY22 Quarterly Activities Report and Appendix 4CJul 26, 2022Quarterly reportASX
Q3 FY22 Quarterly Activities Report and Appendix 4CApr 26, 2022Quarterly reportASX
NT Health upgrade to latest Miya Precision platformApr 18, 2022Other filingsASX
East Lancashire NHS Trust signs 5 year Miya Flow contractApr 5, 2022Other filingsASX
First two renewals for Silverlink PCS solution signedApr 3, 2022Other filingsASX
Dartford & Gravesham expand existing Miya Precision contractMar 31, 2022Other filingsASX
Herefordshire & Worcestershire NHS Trust procures Miya FlowMar 22, 2022Other filingsASX
Alcidion signs Miya Observations agreement with NHS TaysideMar 15, 2022Other filingsASX
S&P DJI Announces March 2022 Quarterly RebalanceMar 4, 2022Other filingsASX
Alcidion H1 FY2022 ResultsFeb 22, 2022Other filingsASX
Alcidion FY22 Appendix 4D and Half Year ReportFeb 22, 2022Interim reportASX
Investor Presentation - Half Year Results - H1 FY2022Feb 22, 2022Interim reportASX
Q2 FY22 Quarterly Activities Report and Appendix 4CJan 26, 2022Quarterly reportASX
Lifting of Trading HaltDec 8, 2021Trading halt or suspensionASX
Completion of Placement and Institutional Entitlement OfferDec 8, 2021FinancingASX
Investor Presentation - Acquisition & Capital RaisingDec 7, 2021FinancingASX
Acquisition of Silverlink and Capital RaisingDec 7, 2021FinancingASX
Pause in TradingDec 6, 2021Trading halt or suspensionASX
Alcidion signs contract with Leidos AustraliaDec 2, 2021Other filingsASX
Q1 FY22 Quarterly Activities Report and Appendix 4COct 25, 2021Quarterly reportASX
Sydney Local Health District expands use of Miya PrecisionOct 17, 2021Other filingsASX
ExtraMed customer base expanded with Queens Hospital BurtonOct 11, 2021Other filingsASX
FY21 Full Year Results ReleaseAug 23, 2021ResultsASX
Appendix 4E - Preliminary Final ReportAug 23, 2021ResultsASX
Q4 FY21 Quarterly Activities Report and Appendix 4CJul 26, 2021Quarterly reportASX
Share Purchase Plan closes strongly oversubscribedMay 5, 2021FinancingASX
Q3 FY2021 Business Update and Appendix 4CApr 27, 2021Quarterly reportASX
ALC selected preferred provider for Dep. of Defence contractApr 14, 2021Other filingsASX
Investor Presentation - Acquisition of ExtraMedApr 14, 2021Acquisition or disposalASX
ALC acquires ExtraMed, completes placement and announces SPPApr 14, 2021FinancingASX
East Lancashire Trust to deploy Patientrack and SmartpageMar 23, 2021Other filingsASX
S&P DJI Announces March 2021 Quarterly RebalanceMar 12, 2021Other filingsASX
Alcidion signs Medications Management contract with NZ DHBsMar 2, 2021Other filingsASX
Investor Presentation - Half Year ResultsFeb 24, 2021Interim reportASX
Alcidion FY21 Half Year Report and Appendix 4DFeb 24, 2021Interim reportASX
Q2 FY2021 Business Update and Appendix 4CJan 26, 2021Quarterly reportASX
$2.0M extension to milestone deal with South Tees NHS TrustDec 13, 2020Other filingsASX
Alcidion expands partnership with NextGate to UK marketNov 24, 2020Other filingsASX
Alcidion signs milestone $9.5M deal with NHS TrustNov 8, 2020Other filingsASX
Q1 FY2021 Business Update and Appendix 4COct 26, 2020Quarterly reportASX
FY2020 Results PresentationSep 8, 2020Other filingsASX
FY2020 Results ReleaseAug 27, 2020Other filingsASX
Q4 FY2020 Business Update and Appendix 4CJul 26, 2020Quarterly reportASX
NHS Lanarkshire to deploy Patientrack across entire boardJul 23, 2020Other filingsASX
Alcidion signs new contract extension with ACT HealthJul 16, 2020Other filingsASX
Murrumbidgee LHD signs contracts for Miya PrecisionJul 13, 2020Other filingsASX
ALC signs contract with Sydney LHD for Miya PrecisionJul 1, 2020Other filingsASX
S&P DJI Announces June 2020 Quarterly RebalanceJun 11, 2020Other filingsASX
Q3 FY2020 Business Update and Appendix 4CApr 27, 2020Quarterly reportASX
NHS Fife extends Patientrack across BoardMar 31, 2020Other filingsASX
Shareholder UpdateMar 15, 2020Other filingsASX
Alcidion FY20 Half Year Report and Appendix 4DFeb 23, 2020Interim reportASX
Investor roadshow presentation and business updateFeb 10, 2020Operations updateASX
Appendix 4C - quarterlyJan 27, 2020Quarterly reportASX
Alcidion signs contract for medications management solutionDec 26, 2019Other filingsASX
3-year deal signed with digital exemplar NHS trust TauntonDec 18, 2019Other filingsASX
ALC Raises $16.2m via Placement to Institutional InvestorsNov 4, 2019FinancingASX
Partnership signed with Healthscope for data and analyticsSep 16, 2019Other filingsASX
FY2019 Results ReleaseAug 28, 2019Other filingsASX
ALC awarded preferred provider for Medications ManagementJul 15, 2019Other filingsASX
Western Sussex Hospitals Renew Patientrack ContractJun 25, 2019Other filingsASX
Alcidion helps NSW Health build CDHRMay 19, 2019Other filingsASX
Brighton and Sussex University Hospitals select PatientrackMar 20, 2019Other filingsASX
Alcidion signs deal with Dartford and Gravesham NHS TrustMar 17, 2019Other filingsASX
Alcidion signs ACT Health Patientrack extensionFeb 25, 2019Other filingsASX
Alcidion FY19 Half Year Report and Appendix 4DFeb 24, 2019Interim reportASX
Alcidion Announces Board and Management ChangesJan 24, 2019Other filingsASX
Alcidion-2 year extension of support services to ACT HealthDec 19, 2018Other filingsASX
Alcidion signs major contract with Queensland HealthNov 25, 2018Other filingsASX
Alcidion FY18 Unaudited Pro Forma ResultsOct 12, 2018Other filingsASX
Alcidion to present at Investor Briefings 5-7 September 18Sep 4, 2018Other filingsASX
Appendix 4E and FY18 Annual Report to shareholdersAug 30, 2018Annual reportASX
Alcidion Appendix 4C - QuarterlyJul 20, 2018Quarterly reportASX
Alcidion signs 3 year contract extension with NT HealthJul 19, 2018Other filingsASX
Alcidion signs $4.75m ACT Health contractJul 5, 2018Other filingsASX
Alcidion completes acquisition of MKM/PatientrackJul 3, 2018Acquisition or disposalASX
Alcidion - MKM Health signs major contract with eHealth NSWJun 12, 2018Other filingsASX
Alcidion - Patientrack contract winsMay 16, 2018Material contractASX
Alcidion to acquire MKM Health and PatientrackApr 23, 2018Acquisition or disposalASX
Alcidion Appendix 4C - CorrectionApr 23, 2018Quarterly reportASX
Alcidion Smartpage goes live at Monash HealthMar 26, 2018Other filingsASX
Alcidion Half Year Report and Appendix 4DFeb 27, 2018Interim reportASX
Alcidion Completes Acquisition of OncallFeb 2, 2018Acquisition or disposalASX
Alcidion Appendix 4C - quarterlyJan 31, 2018Quarterly reportASX
Alcidion to acquire Oncall Systems LtdDec 6, 2017Acquisition or disposalASX
Alcidion AGM PresentationNov 24, 2017Other filingsASX
Alcidion led industry consortium awarded MTPConnect grantOct 26, 2017Other filingsASX
Alcidion secures Mobile Solution deal with Monash HealthOct 4, 2017Other filingsASX
Alcidion Announces Appendix 4E - FY17 Preliminary ReportAug 31, 2017ResultsASX
Miya Smartpage AnnouncementAug 30, 2017Other filingsASX
Alcidion Announcement of Quarterly 4CJul 31, 2017Other filingsASX
Alcidion Announces Miya iSchedulerJul 10, 2017Other filingsASX
Alcidion announce NZD1.60m contract with MidCentral DHBMay 25, 2017Other filingsASX
Alcidion to cease support for RemedyApr 24, 2017Other filingsASX
Alcidion annouces release of Miya ClinicApr 20, 2017Other filingsASX
Alcidion Extend Patient Flow to Katherine HospitalApr 18, 2017Other filingsASX
Alcidion secure $2.35m contract with Western HospitalApr 5, 2017Other filingsASX
Sunshine Coast University Hospital goes live with iCVISMar 30, 2017Other filingsASX
Alcidion and Calvary Health Care CollaborationMar 6, 2017Other filingsASX
Appendix 4C for Q2 FY17Jan 30, 2017Quarterly reportASX
Allure Capital transaction with major shareholdersDec 23, 2016Other filingsASX

This page holds 200 of 243 filings. Open Filings

Open Filings

Cap table

Built by 6ix from Alcidion Group Limited’s releases · as of Nov 15, 2026

Common shares
134,980,515
Fully diluted
134,980,515

Fully diluted

LineSharesAs of
Common shares134,980,515Nov 15, 2026

Share count over time

CountShares
Nov 15, 2026134,980,515
Nov 15, 2026

Open Cap table

Shareholders

HolderSharesValueChangeAs of
Dimensional VA International Small Portfolio58,601US$3,610No changeJul 31, 2026
International Small Company Trust43,339US$3,158No changeJun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Amanda JamesChief People Officer · Since at least Nov 4, 2026
Andrew WayNon-Executive Director · Since at least Nov 5, 2026
Andy SmallmanDirector of Strategic Business Development · Since at least Nov 4, 2026
Daniel SharpNon-Executive Director · Since at least Nov 5, 2026
Julia StevensChief Operating Officer · Since at least Nov 4, 2026
Kate QuirkeGroup Managing Director/Chief Executive Officer · Since at least Nov 4, 2026
Kaye HockingChief Product Officer · Since at least Nov 4, 2026
Matthew GeppChief Financial Officer · Since at least Nov 4, 2026
Nick WhiteChief Marketing Officer · Since at least Nov 4, 2026
Paul DeffleyChief Medical Officer/UK Managing Director · Since at least Nov 4, 2026
All 14 people
PersonSeat
Rebecca WilsonCHAIR · Since at least Nov 5, 2026
Sean WalkerChief Technology Officer · Since at least Nov 4, 2026
Tracy McClellandChief Clinical Information Officer · Since at least Nov 4, 2026
Will SmartNon-Executive Director · Since at least Nov 4, 2026

Open People

Log in to ask 6ix AI your own questions about Alcidion Group Limited.